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Suppression of Integrin Activation:
A Novel Function of a Ras/Raf-Initiated
MAP Kinase Pathway
Paul E. Hughes, Mark W. Renshaw, Martin Pfaff, Thus, there may be active cellular mechanisms to inhibit
integrin activation.Jane Forsyth, Virginia M. Keivens,
Martin A. Schwartz, and Mark H. Ginsberg Transformed fibroblasts often have defects in integrin
function and localization. They are generally less wellDepartment of Vascular Biology
The Scripps Research Institute spread and have poorly developed focal adhesions and
stress fibers (Burridge et al., 1988). In addition, fibronec-La Jolla, California 92037
tin matrix assembly, an integrin activation-dependent
process (Wu et al., 1995), is often lost in transformed
cells (Hynes et al., 1978). Many oncogenes are members
Summary of or interact with cytoplasmic signaling cascades, and
transformation is often a direct result of the deregulation
Rapid modulation of ligand binding affinity (“activa- of a cytoplasmic signal transduction pathway (Cantley
tion”) is a central property of the integrin cell adhesion et al., 1991). This raises the possibility that sustained
receptors. Using a screen for suppressors of integrin activation of cytoplasmic signaling pathways in trans-
activation, we identified the small GTP-binding pro- formed cells could be responsible for the suppression
tein, H-Ras, and its effector kinase, Raf-1, as negative of integrin activation.
regulators of integrin activation. H-Ras inhibited the Chimeric integrins in which theextracellular and trans-
activation of integrins with three distinct a and b sub- membrane domains of the platelet-specific integrin,
unit cytoplasmic domains. Suppression was not asso- aIIbb3, are joined to the cytoplasmic domains of a5, a6A,
ciated with integrin phosphorylation and was inde- a6B, and b1 are constitutively active in CHO cells (O’Toole
pendent of both mRNA transcription and protein et al., 1994). The activation properties of these chimeric
synthesis. Furthermore, suppression correlated with integrins reflect those of the cytoplasmic domain of the
activation ofthe ERK MAP kinase pathway. Thus, regu- parent integrin. For example, aIIbb3 is in a low affinity
lation of integrin affinity state is a novel, transcription- state when expressed in CHO cells. However, the re-
independent function of a Ras-linked MAP kinase placement of the cytoplasmic domains of aIIbb3 with
pathway that may mediate a negative feedback loop those of a5b1, which is in the high affinity state in CHO
in integrin function. cells, produces a chimeric integrin, aIIba5b3b1, that binds
activation-dependent aIIbb3 ligands such as the mono-
clonal antibody PAC1 and fibrinogen with high affinityIntroduction
(O’Toole et al., 1994). Moreover, the activation of this
chimera is energy-dependent, suggesting a requirementInteractions between integrin cell adhesion receptors
for cellular signaling pathways in activating endogenousand their extracellular ligands are central to cell migra-
a5b1. The monoclonal antibody PAC1 is specific for thetion, growth, and survival (Hynes, 1992; Schwartz et al.,
high affinity conformation of aIIbb3, mimickingthe binding1995). A characteristic feature of certain integrins is their
characteristics of the natural ligand, fibrinogen (Shattilability to modulate their affinity for extracellular ligands
et al., 1985). Thus, the combined properties of the activein response to intracellular signals, a process termed
aIIbb3 chimeras and the activation-dependent ligand,“activation” or “inside-out signaling” (reviewed by Wil-
PAC1, permit the use of the extracellular domain of aIIbb3liams et al., 1994). Integrin activation is energy-depen-
as a reporter of cytoplasmic signaling events involveddent and cell type-specific, requiring both the a and
in integrin activation.b subunit cytoplasmic domains (O’Toole et al., 1994;
To identify suppressors of integrin activation, weHughes et al., 1996).
screened a collection of cDNAs for their ability to sup-Several observations suggest that there are cyto-
press PAC1 binding to a CHO cell line expressing anplasmic signaling pathways that suppress integrin acti-
active aIIbb3 chimera. We found that the expression ofvation. For example, integrin activation in T cells is often
activated variants of the small GTP-binding protein,transient, even with continued stimulation (Dustin and
H-Ras, and its kinase effector, Raf-1, blocks integrinSpringer, 1989; Shimizu et al., 1990). Cell migration re-
activation. Furthermore, this suppressive activity corre-quires coordinated adhesion and de-adhesion events,
lates with activation of the ERK MAP kinase pathwayand the“freezing” of integrins in an activated state alters
(extracellular signal–regulated protein kinase [ERK] mi-cell migration (Kuijpers et al., 1993). Platelet-derived
togen-activated protein [MAP] kinase pathway) andgrowth factor inhibits platelet aggregation, suggesting
does not require protein synthesis or mRNA tran-that activation of a tyrosine kinase receptor impairs the
scription.function of integrin aIIbb3 (Vassbotn et al., 1994). During
mitosis, cells become rounded and appear to lose adhe-
sion. Phosphorylation of a conserved serine residue in Results
the b1 cytoplasmic domain may be responsible for this
loss of integrin function in mitotic cells (Hynes, 1992). H-Ras and Activated Raf-1 Kinase
Suppress Integrin ActivationSignaling events initiated by the occupancy of one inte-
grin can suppress functions associated with other inte- Using two-color flow cytometry, we screened a collec-
tion of 102 cDNAs for suppressors of integrin activation.grins (Blystone et al., 1995; Diaz-Gonzalez et al., 1996).
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Figure 1. Suppression of Integrin Activation by Activated H-Ras
ab-py cells were transiently transfected with cDNA encoding Tac-a5 Figure 2. Suppression of Integrin Activation in Transient Transfec-
alone or Tac-a5 plus H-Ras(G12V). After 48 hr, cells were harvested tions
and stained for Tac expression (ordinate) and PAC1 binding (ab-
CHO cells were cotransfected with 2 mg of cDNA encoding aIIba6Ascissa). In the Ras(G12V)-transfected cells there is a leftward shift
and 2 mg of cDNA encoding b3b1. They were also simultaneouslyof the dot plot in the upper but not lower quadrants, representing
cotransfected with 1, 2, or 4 mg of a cDNA encoding R-Ras(G38V),a reduction in PAC1 binding (top left). This shift is reversed by the
Raf-BXB, or H-Ras(G12V). After 48 hr, cells were harvested andaddition of an activating monoclonal antibody, anti-LIBS6, estab-
analyzed for PAC1 binding. The reduction in specific PAC1 bindinglishing that it is due to “deactivation” of the integrin by the
was used to calculate the percentage inhibition relative to thetransfected Ras(G12V) cDNA (top right). In the empty vector trans-
pcDNA3 control. Depicted is the mean percentage inhibition relativefection, there was no suppression of PAC1 binding in the Tac-a5 –
to empty vector 6 SE of three independent determinations.expressing cells (bottom left and bottom right).
These cDNAs encoded cytoskeletal proteins relevant to 2), Cdc42(Q61L), RhoA(Q63L), and Rac-1(Q61L) (data
integrin function (e.g., a-actinin and vinculin), protein not shown) did not suppress integrin activation.
kinases (e.g., focal adhesion kinase [FAK] and protein
kinase C isoforms), and small G proteins (e.g., Rac-1, H-Ras Suppresses the Activation of Integrins
H-Ras, and R-Ras). The cDNAs were grouped into pools with Distinct Cytoplasmic Domains
of six to eight clones and cotransfected into CHO cells To test whether the suppressive effect of activated
stably expressing the active chimeric integrin aIIba6Ab3b1 H-Ras was restricted to the b1 and a6A cytoplasmic do-
(ab-py cells) along with a vector encoding the extracellu- mains, we transiently transfected CHO cells with differ-
lar domain of the Tac subunit of the interleukin-2 recep- ent active aIIbb3 chimeras in the presence or absence of
tor (Tac-a5) (LaFlamme et al., 1992). After 48 hr, the cells 2 mg of H-Ras(G12V) cDNA. We tested chimeras com-
were harvested and analyzed by flow cytometry for anti- posed of the cytoplasmic domains of a6A, a6B, and a5
Tac (to identify transfected cells) and PAC1 (to assess fused to the extracellular and transmembrane domains
integrin affinity state) binding. From this screen we iso- of aIIb. These aIIb subunit chimeras were then coex-
lated three different cDNAs: those encoding both acti- pressed with both native b3 and a b3 chimera containingvated (G12V) and wild-type forms of the small GTP- the cytoplasmic domain of b1. When coexpressed withbinding protein H-Ras (Figure 1) and an activated variant
each chimera, activated H-Ras suppressed PAC1 bind-
of the serine/threonine kinase Raf-1 (Raf-BXB) (data not
ing (Figure 3) by an average of 73% 6 4.2%. Therefore,
shown) that suppressed PAC1 binding (Figure 1). PAC1
the effects of activated H-Ras are not specific for a6Abinding to the H-Ras- or Raf-BXB-transfected cells
and b1 but also extend to other integrin cytoplasmiccould be restored by addition of an “activating” mono-
domains.clonal antibody, anti-LIBS6 (Figure 1), showing that
Activated H-Ras or Raf-1 could suppress integrin acti-there was no reduction in the expression of the recombi-
vation by activating downstream kinases that phosphor-nant integrin following transfection with H-Ras(G12V)
ylate the a6A or b1 cytoplasmic tails. However, we foundor Raf-BXB. Also, suppression was cell-autonomous,
no detectable phosphorylation of aIIba6Ab3b1 followingsince only transfected cells showed a reduction in PAC1
Raf-1 activation even though integrin activation wasbinding (Figure 1).
suppressed (data not shown). This observation sug-To exclude the possibility that the observed effect
gests that phosphorylation of the integrin cytoplasmicdepended on the use of a clonal cell line and the Tac
domains is not required for suppression of integrin acti-marker, we transiently transfected CHO cells with ex-
vation. However, it is possible that rapid and transientpression vectors for both the chimeric integrin and the
phosphorylation occurs below the limits of detection orsuppressor molecules. Both Raf-BXB and H-Ras sup-
before the earliest time point examined (1 hr). There-pressed integrin activation (Figure 2). The effect of acti-
fore, we wished to determine whether the mutation ofvated H-Ras was not a general property of small G pro-
teins, because the transfection of R-Ras(G38V) (Figure certain known phosphorylation sites could block H-Ras–
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part via multiple distinct MAP kinase cascades. Raf-1
is a downstream effector of Ras, leading to the activation
of the ERK1/ERK2 MAP kinases (Howe et al., 1992).
Therefore, the suppressive effect of H-Ras and Raf-BXB
on integrin activation may be mediated by the activation
of one or more of the MAP kinase pathways. To test
this hypothesis we examined the effect of MAP kinase
phosphatase 1 (MKP-1) (Sun et al., 1993) onsuppression
mediated by H-Ras(G12V) and Raf-BXB. ab-py cells
were transiently transfected with H-Ras(G12V) or Raf-
BXB in the presence or absence of MKP-1. Integrin
activation (Figure 4A) and the activation of ERK2 kinase
were then analyzed (Figure 4B). MKP-1 reversed the
activation of ERK2 by H-Ras(G12V) and Raf-BXB and
reduced the inhibition of integrin activation. These re-
sults indicate that the suppressive effects of H-Ras
(G12V) and Raf-BXB are due to the activation of a MAP
kinase pathway.
Since MKP-1 can inactivate both ERK and JNK, we
Figure 3. H-Ras(G12V) Suppresses the Activation of Integrins with sought to determine whether the activation of ERK or
Multiple Cytoplasmic Domains JNK correlated with the inhibition of integrins. ab-py
CHO cells were cotransfected with 2 mg of cDNA encoding aIIba6A cells were transfected with H-Ras(G12V), Raf-BXB, or
and 2 mg of cDNA encoding either wild-type b3, b3(Y747F, Y759F), an activated variant of the small GTP-binding protein
or the chimeras b3b1 or b3b1(S790M). They were simultaneously co- Cdc42(Q61L). Activated Cdc42 stimulates the c-Juntransfected either with 2 mg of cDNA encoding H-Ras G12V or 2 mg
N-terminal kinase (JNK) but not the ERK MAP kinaseof the plasmid pcDNA3 as a control. To determine the effect of
pathway (Minden et al., 1995). The suppression of inte-different a subunit cytoplasmic domains, CHO cells were cotrans-
fected with 2 mg of cDNA encoding the chimera b3b1 and 2 mg of grin activation (Figure 4A) and the activation of MAP
cDNA encoding aIIba6A, aIIba6B, or aIIba5. They were also simultane- kinase pathways were analyzed (Figure 4B). Both
ously cotransfected with either 2 mg of cDNA encoding H-Ras(G12V) H-Ras(G12V) and Raf-BXB, but not Cdc42(Q61L), sup-
or 2 mg of the plasmid pcDNA3. After 48 hr, cells were harvested
pressed integrin activation and activated ERK2. In con-and analyzed for PAC1 binding. The reduction in specific PAC1
trast, Cdc42(Q61L) activated JNK1 but not ERK2. Thesebinding was used to calculate the percentage inhibition relative to
data suggest that the classic MAP kinase cascade lead-the pcDNA3 control. Depicted is the mean percentage inhibition
relative to pcDNA3 6 SE of three to ten independent determinations. ing to ERK1/ERK2 activation, rather than that leading to
JNK activation, is involved in the suppression of integrin
activation by Raf-BXB and H-Ras(G12V).
mediated suppression. We transiently transfected CHO We wished to determine whether the activation of
cells with active variants containing mutations at known endogenous Ras could suppress integrin activation. The
phosphorylation sites. The chimera b3b1(S790M) con- tyrosine kinase Src is known to activate the ERK MAP
tains a methionine substituted for a serine residue phos- kinase pathway in a Ras-dependent manner (Brown and
phorylated in mitotic cells (Hynes, 1992). H-Ras(G12V) Cooper, 1996). Therefore, we examined the ability of
suppressed PAC1 binding to aIIba6Ab3b1(S790M) (Figure two activated forms of Src, Src(E378G) and v-Src, to
3). Therefore, the ability of H-Ras(G12V) to suppress suppress integrin activation in ab-py cells. We found
activation of this mutant is not the result of phosphoryla- that both Src(E378G) and v-Src suppressed PAC1 bind-
tion of S790. The b3 cytoplasmic domain contains two ing (Figure 4C). This suppression was dependent on
tyrosine residues as part of a conserved NPXY and a the activation of the endogenous Ras-dependent MAP
more distal NXXY motif. One or both of these tyrosine kinase pathway, as cotransfection of dominant negative
residues are phosphorylated during thrombin-induced H-Ras(S17N) (Figure 4C) or MKP-1 (data not shown)
platelet aggregation (Law et al., 1996). We substituted markedly reduced the suppressive effect of both forms
both of these tyrosines with phenylalanine in b3(Y747F, of activated Src. Thus, the activation of an endogenous
Y759F), eliminating the possible phosphorylation of Ras can induce suppression of integrin activation.
these residues. H-Ras(G12V) suppressed PAC1 binding
to aIIba6Ab3(Y747F, Y759F) (Figure 3).Therefore, theability
of activated H-Ras to suppress the activation of this Suppression of Integrin Activation Occurs
without Transcription or Protein Synthesismutant was not mediated by the phosphorylation of
tyrosine residues on the b3 cytoplasmic domain. These Activation of the ERK MAP kinase pathway induces
immediate-early gene expression (Marshall,1995). Thus,data indicate that Ras- and Raf-mediated suppression
of integrin activation is not due to the phosphorylation we wished to determine whether the suppression of
integrin activation required the transcription and deof the integrin cytoplasmic domains.
novo synthesis of a suppressive factor. To test this pos-
sibility, we used Raf-ER cells that express the estrogen-Integrin Suppression Correlates with Activation
of a MAP Kinase dependent Raf-1, Raf-1.ER. Upon addition of estradiol,
Raf-1.ER is rapidly activated in the absence of proteinRas plays a central role in the transduction of signals
from growth factor and G protein–coupled receptors, in synthesis (Samuels et al., 1993).
Cell
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In the absence of estradiol, the Raf-ER cells bound assembled an extensive fibronectin matrix that was in-
hibited by the function-blocking anti-a5 antibody PB1PAC1 with high affinity (Figure 5A). However, following
the addition of estradiol, PAC1 binding was reduced (Figure 6). Therefore, in the presence of lamifiban, en-
dogenous a5b1 mediated fibronectin matrix assembly.(Figure 5A) but was restored by addition of the activating
antibody anti-LIBS6. There was no reduction in the Addition of estradiol almost totally blocked fibronectin
matrix assembly by these cells, whereas estradiol hadabundance of aIIba6Ab3b1 following the addition of estra-
diol, as determined by simultaneous anti-aIIbb3 staining no effect on CHO cells lacking Raf-1.ER. To test whether
the inhibition of fibronectin matrix assembly was due to(Figure 5A). In addition, PAC1 binding in the presence
of anti-LIBS6 was the same whether estradiolwas added an estradiol-induced reduction in a5b1 expression in Raf-
ER cells, we measured the number of a5b1 receptors in(fluorescence intensity 5 20 6 5.1 units) or not (fluores-
cence intensity 5 18 6 5 units), further confirming that the presence and absence of estrogen with radiolabeled
PB1 antibody. We found that there were 1.8 3 105 6estradiol did not affect recombinant aIIba6Ab3b1 expres-
sion. The addition of estradiol in the absence of Raf- 2.2 3 104 molecules/cell in the presence of estradiol
compared to 1.8 3 105 6 1.3 3 104 molecules/cell in the1.ER had no effect on PAC1 binding to aIIba6Ab3b1 (Figure
5A). These data indicate that the suppression of PAC1 absence of estradiol. Therefore, Raf-1 activation sup-
presses the capacity of integrin a5b1 tomediate fibronec-binding to Raf-ER cells by estradiol is due to Raf-1 ki-
nase activation. tin matrix assembly without affecting the integrin’s
abundance.We next examined the effect of Raf-1 activation in the
presence of cycloheximide or actinomycin D, inhibitors We next examined the effect of activated Raf-1 on
the morphology of Raf-ER cells plated on fibronectinof protein synthesis and mRNA transcription, respec-
tively. In the absence of estradiol, both cycloheximide and fibrinogen. In the absence of estradiol, Raf-ER cells
adhered and spread normally on both fibrinogen and(20 mg/ml) and actinomycin D (2 mg/ml) had little effect
on PAC1 binding to Raf-ER cells (Figure 5B). In the fibronectin. Activation of Raf-1 following the addition of
estradiol to the culture medium resulted in a profoundpresence of both estradiol and either cycloheximide (20
mg/ml) or actinomycin D (2 mg/ml), PAC1 binding was effect on cell shape (Figures 6E and 6F). The cells lost
their spread phenotype and adopted a more roundednearly completely inhibited. Total protein synthesis was
inhibited by 98% in the cells treated with 20 mg/ml cyclo- shape (Figure 6F). There were no changes in the mor-
phology of the cells lacking activated Raf-ER.heximide either in the presence or absence of estradiol,
as assessed by incorporation of [35S]methionine into tri-
chloroacetic acid–insoluble protein. Thus, the sup-
Discussionpressive effect of activated Raf-1 does not require sub-
stantial mRNA transcription or protein synthesis.
We report the identification and characterization of aWe used the Raf-ERcells to determine the time course
signal transduction pathway that leads to the suppres-of suppression following the activation of Raf-1. Raf-
sion of integrin activation. The major findings are asER cells were treated with cycloheximide to block up-
follows. First, this suppression pathway involves theregulation of MKP-1 (Sun et al., 1993). PAC1 binding
small GTP-binding protein H-Ras and its downstreamand ERK2 kinase activity were then assayed in parallel
effector kinase Raf-1. Second, activated H-Ras sup-at hourly intervals from 0 to 4 hr after the addition of
presses the activation of integrins with multiple a andestradiol. After 1 hr, ERK2 activity was near maximal,
b subunit cytoplasmic domains. The suppressive effectas expected (Samuels et al., 1993). However, suppres-
is not associated with integrin phosphorylation, nor ission of PAC1 binding was delayed (Figure 5C). After 2
it reversed by mutations that eliminate certain knownhr, integrin activation was suppressed by 60%, with
phosphorylation sites in the b3 or b1 cytoplasmic do-maximal suppression reached after 3 hr (Figure 5C). The
mains. Third, the suppression of integrin activation byaddition of cycloheximide alone to Raf-ER cells had no
H-Ras(G12V) and Raf-BXB correlates with activation ofeffect on PAC1 binding to aIIba6Ab3b1 (data not shown).
the ERK but not the JNK MAP kinase pathway. Fourth,
the suppressive effect of Raf-1 does not require mRNAActivation of Raf-1 Suppresses Fibronectin Matrix
transcription or protein synthesis. These data identifyAssembly and Changes Integrin-Dependent
integrin affinity state as a novel, transcription-indepen-Cell Morphology
dent target of Ras-initiated MAP kinase pathways. TheyTo determine whether this suppression pathway could
also provide a cogent explanation for the alteration ofinhibit other integrin-dependent functions, we examined
certain integrin-dependent functions in many trans-the effect of activated Raf-1 on fibronectin matrix as-
formed cells.sembly and cell morphology. In these experiments, we
Expression of activated variants of the small GTP-used the Raf-ER cells in which Raf-1 kinase activity is
binding protein H-Ras and the serine/threonine kinasecontrolled by the presence of exogenous estradiol.
Raf-1 blocked integrin activation. This result was ob-We examined the effect of activated Raf-1 on a5b1-
served with a series of chimeric integrins in which themediated fibronectin matrix assembly, a process requir-
extracellular and transmembrane domains of aIIbb3 wereing an activated integrin (Wu et. al., 1995). Because the
joined to the cytoplasmic domains of a6A, a6B, and a5Raf-ER cells could use the recombinant aIIba6Ab3b1 to
and b1. Each of these a subunit cytoplasmic domainsassemble a matrix, we added saturating quantities of
has a highly distinct sequence. In contrast, both thean aIIbb3 specific inhibitor, lamifiban, to all samples to
b1 and b3 tails share homologous sequence motifs inensure that matrix assembly was mediated only by en-
dogenous a5b1. In the absence of estradiol, Raf-ER cells common with other b subunit cytoplasmic domains. This
Suppression of Integrin Activation
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raises the possibility that the suppression pathway is
acting in a b subunit–dependent manner or, alterna-
tively, that it is capable of acting via multiple a subunit
cytoplasmic domains. Earlier reports suggested that the
tyrosine phosphorylation of either b1 or b3 subunit cyto-
plasmic domains can influence integrin function and
localization (Johansson et al., 1994; Law et al., 1996).
However, activated H-Ras was able to suppress the
activation of the double mutant aIIba6Ab3(Y747F, Y759F),
demonstrating that suppression is not the result of the
phosphorylation of tyrosine residues in the b3 cyto-
plasmic domain. In addition, activated H-Ras was able
to suppress the activation of aIIba6Ab3b1(S790M). The ser-
ine residue substituted with methionine in b3b1(S790M)
corresponds to the serine phosphorylated in mitotic
cells (Hynes, 1992). This result shows that this effect is
distinct from the reported effects of S790 phosphoryla-
tion and represents a second potential mechanism for
regulation of integrin function in concert with the cell
cycle.
The inhibition of integrin activation by activated H-Ras
and Raf-1 correlated with activation of the ERK but not
the JNK MAP kinase pathway. Ras plays a pivotal role
in the transduction of signaling events initiated by both
tyrosine kinase growth factor receptors and G protein–
coupled receptors. Activated Ras can interact with mul-
tiple downstream effectors, controlling both gene ex-
pression and the organization of the actin cytoskeleton
(reviewed by Hall, 1992). Given that the other Ras family
members, N-Ras and K-Ras, have downstream effectors
similar to those of H-Ras, these Ras family members
would also be expected to suppress integrin activation.
Indeed, an activated variant of K-Ras(C12V) suppresses
PAC1 binding to ab-py cells (Ginsberg and Forsyth, un-
published data). Raf-1 is a downstream effector of H-Ras
that induces the activation of the ERK1/ERK2 MAP ki-
nases (Howe et al., 1992). Because Raf-1 had a sup-
pressive effect similar to that of activated H-Ras, integrin
suppression may be mediated by the activation of one
or more of the MAP kinase pathways. Moreover, MKP-1,
a MAP kinase phosphatase, partially reversed the sup-
pressive effect of both activated H-Ras and Raf-1. In
the same experiment, MKP-1 completely reversed acti-
vation of recombinant ERK2 induced by activated Raf
phorylation of GST-Jun (1-79). (Top) Relative ERK and JNK activity.
Figure 4. Suppression of Integrin Activation Correlates with Activa- Note the activation of ERK2 by Ras(G12V) and Raf-BXB. In addition,
tion of the ERK1/ERK2 MAP Kinase Cascade note the inhibition of ERK2 activity by MKP-1. Activated Cdc42
(A) ab-py cells were cotransfected with 2 mg of expression vector failed to activate ERK2 butactivated JNK1. Immunoblotting revealed
or vectors bearing inserts encoding Cdc42(Q61L), Raf-BXB, or an equivalent amount of ERK2 and JNK1 in each of the kinase
Ras(G12V). In separate transfections, 2 mg of Raf-BXB or Ras(G12V) reactions (data not shown). (Bottom) Immunoblots with the anti-HA
cDNA were cotransfected with 6 mg of a plasmid encoding MKP-1. antibody 12CA5. There was a comparable expression of either HA-
After 48 hr, PAC1 binding was determined by flow cytometry. De- tagged ERK2 or JNK1 in all transfections. The Ras(G12V) construct
picted is the mean percentage inhibition relative to empty vector 6 bore an HA-tag and was detected as the the lower band in lanes
SE of three independent determinations. transfected with that construct. Note the similar expression of re-
(B) ab-py cells were cotransfected with 2 mg of an expression vector combinant activated Ras in both the control and MKP-1-cotrans-
encoding HA-tagged ERK2 or HA-tagged JNK1. The cells were also fected cells.
cotransfected with 2 mg of expression vector (None) or vectors (C) ab-py cells were transfected with 4 mg of an expression vector
containing inserts encoding Cdc42(Q61L), Raf-BXB, or Ras(G12V). encoding either v-Src or Src(E378G). In separate transfections, 4
In separate transfections, 2 mg of expression vectors encoding either mg of expression vectors encoding either Src(E378G) or v-Src were
Raf-BXB or Ras(G12V) were simultaneously cotransfected with 6 simultaneously cotransfected with 1 mg of a plasmid encoding domi-
mg of a plasmid encoding MKP-1. The transfected kinases were nant negative Ras(S17N). After 48 hr, integrin activation was deter-
immunoprecipitated with anti-HA antibody 12CA5. ERK2 activity mined by PAC1 binding. Depicted is the mean percentage inhibition
was measured by phosphorylation of myelin basic protein by an in- relative to the empty vector control 6 SE of three independent
gel kinase assay, and JNK-1 activity was measured by the phos- determinations.
Cell
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Figure 5. The Suppression of Integrin Activa-
tion by Raf-1 Is Independent of Transcription
and Protein Synthesis
(A) Raf-ER cells or CHOaIIba6Ab3b1 cells were
incubated in the presence or absence of es-
tradiol for 24 hr. The cells were then harvested
and double-stained for integrin expression
(ordinate) and PAC1 binding (abscissa). In the
Raf-ER cells (top graphs) there is a leftward
shift of the dot plot following the addition of
estradiol, representing a reduction in PAC1
binding. The reduction in PAC1 binding can
be restored by the addition of the activating
antibody anti-LIBS6. The number in the top
right corner of the graphs represents the acti-
vation index in the absence or presence of
estrogen. The addition of estrogen had no
effect on PAC1 binding to CHO cells express-
ing aIIba6Ab3b1 in the absence of Raf-1ER (bot-
tom graphs).
(B) Flow cytometry histograms illustrating
PAC1 binding to Raf-ER cells in the presence
(shaded line) or absence (solid line) of 1 mM
competitive inhibitor Ro43–5054 and in the
presence of either cycloheximide or actino-
mycin D. In the absence of estradiol, both
the cycloheximide and actinomycinD-treated
cells bound PAC1, showing that the aIIbb3 chi-
mera was in the high affinity state. The pres-
ence of estradiol blocked PAC1 binding to
both the cycloheximide and actinomycin
D-treated cells.
(C) Raf-ER cells were cultured in the presence
of estrogen and cycloheximide over a 4 hr
period. The cells were then harvested at the
time points indicated and analyzed for PAC1
binding and ERK2 kinase activity. The reduc-
tion in specific PAC1 binding was used to
calculate the percentage inhibition of integrin
activation relative to the cycloheximide-alone
control. Integrin activation was suppressed
within 2 hr after the addition of estradiol, with
maximal suppression reached after 3 hr.
There was at least a 2 hr lag between ERK2
activation and maximal suppression of inte-
grin activation.
and Ras. This difference suggests thepossibility of addi- mediated by a MAP kinase–dependent integrin suppres-
sion pathway. MKP-1 can dephosphorylate and there-tional MAP kinase–independent pathway(s) that sup-
press integrin activation. Alternatively, endogenous fore inactivate ERK, JNK, and p38 kinases (Chu et al.,
1996). However, we found that the suppression of inte-ERK’s orother MAP kinases mayhave been only partially
inactivated by the transfected MKP-1. Nevertheless, it grin activation correlated with activation of the ERK but
not the JNK MAP kinase pathway.is clear that the effect of activated Ras and Raf was
Suppression of Integrin Activation
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Figure 6. Changes in Fibronectin Matrix As-
sembly and Integrin-Dependent Cell Mor-
phology Induced by Activated Raf-1
Raf-ER cells were cultured in medium supple-
mented with human fibronectin (150 mg/ml)
and the aIIbb3- specific inhibitor lamifiban (1
mM). Cells cultured in the absence of estradiol
(A) assembled an extensive fibronectin ma-
trix. In contrast, fibronectin matrix assembly
was reduced in cells grown in the presence
of estradiol (B). In the absence of estradiol,
fibronectin matrix assembly was completely
inhibited in Raf-ER cells following the addi-
tion of the anti-a5 antibody PB1 (C). Estradiol
had no effect in cells lacking Raf-1.ER (D). To
determine the effect of activated Raf-1 on
the adhesive phenotype, Raf-ER cells were
plated on fibrinogen-coated coverslips (5 mg/
ml) and cultured in the absence (E) or pres-
ence (F) of estradiol for 24 hr. Cells cultured
in the absence of estradiol (E) exhibited a
normal spread morphology. In contrast, cells
plated on fibrinogen in the presence of estra-
diol were less well spread and displayed a
more rounded phenotype (F). Identical results
were obtained for cells plated on fibronectin
(not shown).
Activated variants of the tyrosine kinase Src could induced inhibition. These two findings suggest that sup-
pression is the result of downstream signaling eventsalso suppress integrin activation via a Ras-dependent
MAP kinase pathway. These results establish that the initiated by H-Ras. Thus, H-Ras-mediated suppression
does not appear to be the consequence of simple com-activation of endogenous Ras can also inhibit integrin
activation. In addition, the fact that overexpressed wild- petition between H-Ras and R-Ras for common ef-
fectors. It would be of interest to determine whethertype H-Ras also inhibited PAC1 binding establishes that
the suppressive effect of H-Ras(G12V) is not due to its R-Ras “activation” of integrins is the result of competi-
tion with Ras for its effectors.ability to interact with a downstream effector unique to
the activated variant. Thus, transformation initiated by Using a conditionally activated Raf-1, we found that
the suppressive effect of activated Raf-1 was largelyoncogenes upstream of Ras can also engage this inte-
grin suppression pathway. independent of de novo transcription and protein syn-
thesis. The conditional Raf-1 was directly activated byZhang et al. (1996) reported that R-Ras, a Ras-related
small G protein, could “activate” integrins. R-Ras and the addition of exogenous estradiol, and this led to the
suppression of integrin activation. In the presence ofH-Ras have similar effector binding domains and bind
many of the same effectors, including Raf and Ral-GDS inhibitors of mRNA transcription and protein synthesis,
the suppressive effect of Raf-1 was maintained. Thus,(Urano et al., 1996). However, R-Ras and H-Ras have
different morphological effects oncells (Cox et al., 1994), Raf-1-mediated integrin suppression was independent
of protein synthesis. The estrogen-dependent Raf-1 al-possibly because R-Ras may not activate some of the
Ras effectors to which it binds. Thus, R-Ras could block lowed us to determine the time interval between the
activation of Raf-1 and the loss of PAC1 binding. Bythe suppressive effect of H-Ras by competition for com-
mon effectors. Alternatively, activated H-Ras could act monitoring both ERK2 kinase activity and integrin acti-
vation we found that maximal suppression was notas a dominant negative inhibitor with respect to the
specific effectors of R-Ras involved in integrin activa- reached until after 3 hr after Raf-1 activation. In contrast,
ERK2 kinase activity was maximal 1 hr after addition oftion. However, Raf-1, a downstream effector of H-Ras,
induced suppression of integrin activation.Furthermore, estradiol. Therefore, there appears to be a lag period of
at least 2 hr between the activation of the ERK MAPa MAP kinase phosphatase, MKP-1, reversed H-Ras–
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kinase pathway and the suppression of PAC1 binding. inhibition could be the direct result of the activation of
a MAP kinase–dependent integrin suppression pathway.This assay measures the time interval between Raf-1
activation and the loss of PAC1 binding to a previously Deregulation of the MAP kinase pathway isoften asso-
ciated with oncogenic transformation, suggesting thatactivated integrin. One explanation for this lag period is
that the activation of the MAP kinase pathway may initi- malignant transformation could produce a sustained ac-
tivation of this integrin suppression pathway. Unregu-ate the disassembly of an integrin “activation” complex.
Alternatively, it is possible that integrins on the cell sur- lated action of an integrin suppression pathway may
help to explain some of the characteristics of the trans-face cycle between active and inactive states and that
the integrin suppression pathway may act by sup- formed phenotype, such as the loss of fibronectin matrix
assembly and altered cell migration and morphology.pressing only the activation step. Thus, the lag period
could be due to the time required for the previously Indeed, we show that a conditionally active Raf-1 is
able to inhibit integrin a5b1–mediated fibronectin matrixactive receptors to lose the capacity to bind PAC1.
Our results indicate that integrin suppression is medi- assembly and induce changes in integrin-dependent cell
morphology. Moreover, it is likely that a cytoplasmicated by transcription-independent signaling through a
MAP kinase pathway. There are examples of cytosolic substrate(s) of a MAP kinase are involved in suppres-
sion, since de novo protein synthesis is not required.signaling events downstream of MAP kinases. For ex-
ample, MAP kinases can phosphorylate and thus acti- Thus, these data point to a novel Ras-initiated effector
pathway that is responsible for some of the phenotypicvate cytoplasmic phospholipase A2 in vitro (Lin et al.,
1993) and MAP kinase can phosphorylate the gap junc- alterations frequently found in transformed cells.
tion protein connexin 43 (Kanemitsu and Lau, 1993).
Experimental ProceduresHowever, the biological significance of these events has
yet to be determined. We found that a cellular function,
Antibodies and Reagentsintegrin activation, is regulated by transcription-inde-
The anti-aIIbb3 monoclonal antibodies anti-LIBS6 and D57 have been
pendent signaling through a MAP kinase pathway. Thus, described previously (O’Toole et al., 1994). The anti-aIIbb3 mono-
we provide evidence for novel cytoplasmic signaling clonal antibody PAC1 (Shattil et al., 1985) and the anti-hamster
a5 antibody PB1 were generous gifts from Dr. S. Shattil (Scrippstargets of the MAP kinase pathway. It will be of great
Research Institute) andDr. R. L. Juliano (University of North Carolina,interest to identify the elements of this pathway.
Chapel Hill). The anti-Tac antibody, 7G7B6, was obtained from theThe classic MAP kinase pathway can be activated
American Type Culture Collection (Rockville, Maryland). Antibodiesby the dimerization of growth factor receptor tyrosine
7G7B6 and D57 were biotinylated with biotin-N-hydroxy-succini-
kinases and by the ligation and clustering of integrins mide (Sigma) according to the manufacturer’s directions. The aIIbb3-
(Schlaepfer et al., 1994; Marshall, 1995). In both events, specific peptidomimetic inhibitors Ro44–9883 (lamifiban) and Ro43–
5054 (Alig et al., 1992) were generous gifts from Dr. B. Steiner (F.Ras activation is thought to be mediated by the translo-
Hoffmann, La Roche, Basel).cation of a complex between the adapter protein GRB-2
and the guanine nucleotide exchange factor SOS to
cDNA Constructs, Transfection, and Cell Linesthe plasma membrane (Clark and Hynes, 1996). This
The expression vectors encoding the aIIb and b3 chimeras, aIIba6B,
suggests that integrin- and growth factor-derived sig- aIIba6A, aIIba5, b3b1, and b3b1(S790M), have been described previously
nals could engage the MAP kinase-dependent integrin (O’Toole et al., 1994, 1995). b3(Y747F, Y759F) was constructed by
splice-overlap polymerase chain reaction mutagenesis. pDCR-H-suppression pathway described in this work. Ras and
Ras(G12V) was a gift from Dr. M. H. Wigler (Cold Spring HarborRaf activation occurs at the plasma membrane (Leevers
laboratory) (White et al., 1995). pcDNA3-R-Ras(G38V) (Zhang et al.,et al., 1994), and integrin suppression does not require
1996) was a gift from Dr. E. Ruoslahti (The Burnham Institute, Laprotein synthesis. This raises the possibility that the
Jolla) with permission from Dr. Alan Hall (University of London).
integrin suppression pathway forms a local negative pCEP4 Raf-1:ER was a gift from Dr. A. Thorburn (University of Utah)
feedback loop for the regulation of integrin function. with permission of Dr. M. McMahon (DNAX Research Institute).
pGEX GST–Jun (1–79) and pSRa3 HA-JNK1 (Minden et al., 1994)There are several observations that support this hypoth-
were gifts from Dr. M. Karin (University of California, San Diego).esis. The integrin-dependent activation of ERK’s is tran-
The wild-type H-Ras cDNA was a gift from Dr. J. Jackson (Universitysient and may require Ras activation (Clark and Hynes,
of California, San Diego). pCMV5 Cdc42(Q61L) was a gift from Dr.1996). In this context Ras activation could occur via
G. Bokoch (Scripps Research Institute). The vectors encoding Raf-
the formation of a complex of FAK, GRB-2, and SOS BXB, HA-ERK2 and v-Src have been described previously (Bruder
(Schlaepfer et al., 1994). Cells derived from FAK-defi- et al., 1992; Devary et al., 1992; Renshaw et al., 1996). pSG5 MKP-1
cient mice show enhanced focal adhesion formation, was a gift from Dr. N. Tonks (Cold Spring Harbor laboratory) (Sun
et al., 1993). pBK-CMV Src(E378G) (Levy et al., 1986) was a gift fromsuggesting that these cells may have lost a negative
Dr. J. Brugge (Ariad Pharmaceuticals).regulator of integrin function (Illc et al., 1995). In addition,
The ab-py cells were generated by stably transfecting CHO-K1dominant negative Ras can enhance focal adhesion for-
cells with pPSVE-PyE (a generous gift from M. Fukuda, The Burnham
mation (Clark and Hynes, 1996). Further evidence for Institute) encoding the polyoma large T antigen and replication-
the existence of a negative feedback loop comes from deficient CDM8 expression constructs encoding aIIba6A and b3b1.
observations that integrin occupancy or the expression Raf-1.ER cells were generated by stably transfecting CHO-K1 cells
with the hygromycin-resistant vector pCEP Raf-1:ER and expressionof isolated b subunit cytoplasmic domains can suppress
constructs encoding aIIba6A and b3b1.the function of other integrins (trans-dominant inhibition)
(Chen et al., 1994; Lukashev et al., 1994; Blystone et al.,
Flow Cytometry
1995). Both occupied integrins and isolated integrin b PAC1 binding was analyzed by two-color flow cytometry as de-
subunit cytoplasmic domains can initiate cytoplasmic scribed (Hughes et al., 1996). In transiently transfected CHO-K1 or
signaling cascades (Lukashev et al., 1994). This raises ab-py cells, PAC1 binding was analyzed only on a gated subset of
cells positive for aIIbb3 or Tac-a5 expression. To examine the effectsthe possibility that some instances of trans-dominant
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of inhibitors of protein synthesis and transcription on the sup- examined by phase-contrast microscopy. Photographs were then
taken on Tmax 400 film.pressive effect of activated Raf-1, cycloheximide (20 mg/ml) or acti-
nomycin D (2 mg/ml) was added to Raf-ER cells for 24 hr in the
presence and absence of estradiol (13 mM). The cells were then Acknowledgments
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